Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-2-13
pubmed:abstractText
The literature of the last 4 years confirms that the anti-CCP2 test is a very useful marker for the early and specific diagnosis of rheumatoid arthritis (RA). The anti-CCP2 test is very specific for RA (95-99%) and has sensitivity comparable to that of the rheumatoid factor (70-75%). The antibodies can be detected very early in the disease and can be used as an indicator for the progression and prognosis of RA. In this review, these interesting properties and some future possibilities of this diagnostic test are discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-10643712, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-11840437, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-11982605, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-12847215, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-13130468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-14558078, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-14558095, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-15022309, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-15225365, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-15529392, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-15640269, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16188946, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16200610, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16255021, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16320316, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16396980, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16507117, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16511941, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16572283, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16859515, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16859519, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16870095, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-16924694, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-17075816, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-17110315, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-17133560, http://linkedlifedata.com/resource/pubmed/commentcorrection/18270856-7516431
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1559-0267
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.
pubmed:affiliation
Department of Biomolecular Chemistry, Radboud University Nijmegen, Nijmegen, The Netherlands. w.vanvenrooij@ncmls.ru.nl
pubmed:publicationType
Journal Article, Review